Cancer treatment by electroporation method
Not Applicable
Recruiting
- Registration Number
- IRCT20190904044697N8
- Lead Sponsor
- Iran Nano Fund
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
Cancer patients who have different types of cancer with solid tumors.
cancer stage IA, IB, IIA, IIB, IIIA, IIIB, IV
(Karnofsky Score = ??)
Patients with different types of benign and malignant tumors
Exclusion Criteria
Pregnancy
Coagulation disorder (INR more than 1.5 times control)
Platelets less than 100,000
Anemia (hemoglobin less than 10)
Serious acute infection
Having an implanted pacemaker, defibrillator or deep brain stimulator or cardiac arrhythmias.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Tumor size. Timepoint: Every two weeks. Method of measurement: Imaging modalities (Conventional ultrasound and especially Doppler ultrasound, MRI and CT scan).;Clinical and quality of life changes. Timepoint: Every week. Method of measurement: Investigating of Clinical Manifestation.;Tumor cell death. Timepoint: every three month. Method of measurement: Immunostaining, Immunohistochemistry, H&E.;Metastasis to other organs. Timepoint: Every 6 month. Method of measurement: Imaging by MRI, CT or PET scan.
- Secondary Outcome Measures
Name Time Method Quality Of Life. Timepoint: 90 days. Method of measurement: Questionnaire about quality of life indicators based on EORTC QLQ-C30.